| Dr K Kent Chevli, MD | |
|
3085 Harlem Rd, Ste 200, Cheektowaga, NY 14225-2563 | |
| (716) 844-5000 | |
| (716) 844-5050 |
| Full Name | Dr K Kent Chevli |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 35 Years |
| Location | 3085 Harlem Rd, Cheektowaga, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215934781 | NPI | - | NPPES |
| 000523274005 | Other | NY | BCBS OF WNY |
| 01482255 | Medicaid | NY | |
| 195675-4 | Other | NY | WORKERS COMP |
| 040426000815 | Other | NY | FIDELIS |
| 1909181 | Other | NY | INDEPENDENT HEALTH |
| 1000375 | Other | NY | GHI |
| 00010029501 | Other | NY | UNIVERA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 195675 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaleida Health | Buffalo, NY | Hospital |
| Erie County Medical Center | Buffalo, NY | Hospital |
| Olean General Hospital | Olean, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Great Lakes Physician Pc | 9133434269 | 61 |
News Archive
Transgene SA (Paris:TNG) said today that it welcomed the announcement by SillaJen, Inc. of its intention to acquire Jennerex, Inc. and has consequently given its consent to the definitive merger agreement.
Renhuang Pharmaceuticals, Inc., a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM"), today announced that on March 28, 2010, the Company's patent application for its proprietary Siberian Ginseng (Acanthopanax) Total Glucosides Total Flavonoids Soft Capsules and related formulation method passed a preliminary review conducted by the State Intellectual Property Office of the People's Republic of China ("SIPO").
A Mayo Clinic-led study involving 488 cardiac patients whose cases were followed for up to 12 years finds that microvascular endothelial dysfunction, a common early sign of cardiovascular disease, is associated with a greater than twofold risk of cancer.
There are many unanswered questions about COVID-19. A Kansas State University infectious disease scientist and collaborators are offering a possible research road map to find the answers.
› Verified 2 days ago
| Entity Name | Erie County Medical Center Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528233616 PECOS PAC ID: 1456308907 Enrollment ID: O20050715000538 |
News Archive
Transgene SA (Paris:TNG) said today that it welcomed the announcement by SillaJen, Inc. of its intention to acquire Jennerex, Inc. and has consequently given its consent to the definitive merger agreement.
Renhuang Pharmaceuticals, Inc., a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM"), today announced that on March 28, 2010, the Company's patent application for its proprietary Siberian Ginseng (Acanthopanax) Total Glucosides Total Flavonoids Soft Capsules and related formulation method passed a preliminary review conducted by the State Intellectual Property Office of the People's Republic of China ("SIPO").
A Mayo Clinic-led study involving 488 cardiac patients whose cases were followed for up to 12 years finds that microvascular endothelial dysfunction, a common early sign of cardiovascular disease, is associated with a greater than twofold risk of cancer.
There are many unanswered questions about COVID-19. A Kansas State University infectious disease scientist and collaborators are offering a possible research road map to find the answers.
› Verified 2 days ago
| Entity Name | Great Lakes Physician Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659310092 PECOS PAC ID: 9133434269 Enrollment ID: O20150818004788 |
News Archive
Transgene SA (Paris:TNG) said today that it welcomed the announcement by SillaJen, Inc. of its intention to acquire Jennerex, Inc. and has consequently given its consent to the definitive merger agreement.
Renhuang Pharmaceuticals, Inc., a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM"), today announced that on March 28, 2010, the Company's patent application for its proprietary Siberian Ginseng (Acanthopanax) Total Glucosides Total Flavonoids Soft Capsules and related formulation method passed a preliminary review conducted by the State Intellectual Property Office of the People's Republic of China ("SIPO").
A Mayo Clinic-led study involving 488 cardiac patients whose cases were followed for up to 12 years finds that microvascular endothelial dysfunction, a common early sign of cardiovascular disease, is associated with a greater than twofold risk of cancer.
There are many unanswered questions about COVID-19. A Kansas State University infectious disease scientist and collaborators are offering a possible research road map to find the answers.
› Verified 2 days ago
| Entity Name | Harlem Road Ambulatory Surgery Center Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1588328918 PECOS PAC ID: 7810388238 Enrollment ID: O20211220000734 |
News Archive
Transgene SA (Paris:TNG) said today that it welcomed the announcement by SillaJen, Inc. of its intention to acquire Jennerex, Inc. and has consequently given its consent to the definitive merger agreement.
Renhuang Pharmaceuticals, Inc., a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM"), today announced that on March 28, 2010, the Company's patent application for its proprietary Siberian Ginseng (Acanthopanax) Total Glucosides Total Flavonoids Soft Capsules and related formulation method passed a preliminary review conducted by the State Intellectual Property Office of the People's Republic of China ("SIPO").
A Mayo Clinic-led study involving 488 cardiac patients whose cases were followed for up to 12 years finds that microvascular endothelial dysfunction, a common early sign of cardiovascular disease, is associated with a greater than twofold risk of cancer.
There are many unanswered questions about COVID-19. A Kansas State University infectious disease scientist and collaborators are offering a possible research road map to find the answers.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr K Kent Chevli, MD 3085 Harlem Rd, Suite 200, Cheektowaga, NY 14225-2563 Ph: (716) 844-5600 | Dr K Kent Chevli, MD 3085 Harlem Rd, Ste 200, Cheektowaga, NY 14225-2563 Ph: (716) 844-5000 |
News Archive
Transgene SA (Paris:TNG) said today that it welcomed the announcement by SillaJen, Inc. of its intention to acquire Jennerex, Inc. and has consequently given its consent to the definitive merger agreement.
Renhuang Pharmaceuticals, Inc., a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM"), today announced that on March 28, 2010, the Company's patent application for its proprietary Siberian Ginseng (Acanthopanax) Total Glucosides Total Flavonoids Soft Capsules and related formulation method passed a preliminary review conducted by the State Intellectual Property Office of the People's Republic of China ("SIPO").
A Mayo Clinic-led study involving 488 cardiac patients whose cases were followed for up to 12 years finds that microvascular endothelial dysfunction, a common early sign of cardiovascular disease, is associated with a greater than twofold risk of cancer.
There are many unanswered questions about COVID-19. A Kansas State University infectious disease scientist and collaborators are offering a possible research road map to find the answers.
› Verified 2 days ago
Gina Nicole Tundo, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 3085 Harlem Rd Ste 200, Cheektowaga, NY 14225 Phone: 716-844-5000 Fax: 716-844-5750 | |
Karl-dietrich Max Gustav Sievert, Urology Medicare: Not Enrolled in Medicare Practice Location: 3085 Harlem Rd Ste 200, Cheektowaga, NY 14225 Phone: 716-844-5000 Fax: 716-844-5750 | |
Dr. John Joseph Bodkin Iii, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 3085 Harlem Rd Ste 200, Cheektowaga, NY 14225 Phone: 716-844-5000 Fax: 716-844-5050 | |
Kevin J Barlog, M.D. Urology Medicare: Medicare Enrolled Practice Location: 3085 Harlem Rd, Ste 200, Cheektowaga, NY 14225 Phone: 716-844-5000 Fax: 716-844-5050 | |
David J. Abramowitz, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 3085 Harlem Rd Ste 200, Cheektowaga, NY 14225 Phone: 716-844-5000 Fax: 716-844-5750 | |
Teresa Louise Danforth, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 3085 Harlem Rd Ste 200, Cheektowaga, NY 14225 Phone: 716-844-5000 Fax: 716-844-5750 |